Just for the record, I am NOT ruling out Herceptin/HER2 TKI combo at all. All I was saying was based on clinical trial results from various agents up to today, it is quite possible and very plausible Herceptin/ERRB1-4 has some advantage over Herceptin/HER2 TKI.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.